Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
European Cytokine Network
|
February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation
N Vey, P Viens, C Fossat, et al.
Cytotherapy
|
June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
M Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation
|
February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
H de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation
|
February 14, 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission
H de Lavallade, C Faucher, S Fürst, et al.
Bone Marrow Transplantation
|
September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
M Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation
|
January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
J El-Cheikh, C Faucher, S Fürst, et al.
Leukemia & Lymphoma
|
August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution
S Oddou, N Vey, P Viens, et al.
Histopathology
|
February 26, 2000
Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma
M C Charton-Bain, P Brousset, R Bouabdallah, et al.
Bone Marrow Transplantation
|
June 27, 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma
R Crocchiolo, L Castagna, S Fürst, et al.
Bone Marrow Transplantation
|
September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies
N Vey, B De Prijck, C Faucher, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
European Cytokine Network
|
February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation
N Vey, P Viens, C Fossat, et al.
Cytotherapy
|
June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
M Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation
|
February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
H de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation
|
February 14, 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission
H de Lavallade, C Faucher, S Fürst, et al.
Bone Marrow Transplantation
|
September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
M Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation
|
January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
J El-Cheikh, C Faucher, S Fürst, et al.
Leukemia & Lymphoma
|
August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution
S Oddou, N Vey, P Viens, et al.
Histopathology
|
February 26, 2000
Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma
M C Charton-Bain, P Brousset, R Bouabdallah, et al.
Bone Marrow Transplantation
|
June 27, 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma
R Crocchiolo, L Castagna, S Fürst, et al.
Bone Marrow Transplantation
|
September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies
N Vey, B De Prijck, C Faucher, et al.
Page
of 14